Second-Degree Type 2 Atrioventricular Block Requiring Permanent Cardiac Pacing in Patients on CDK4/6 Inhibitors: Report of Two Cases - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/35957944/
To our knowledge, these are the first cases reported in the literature of new-onset advanced AV blocks in patients under treatment with CDK4/6Is, suggesting the clinical relevance of a more frequent ECG monitoring, besides the QT interval, in these patients.
Conclusion: To our knowledge, these are the first cases reported in the literature of new-onset advanced AV blocks in patients under treatment with CDK4/6Is, suggesting the clinical relevance of a more frequent ECG monitoring, besides the QT interval, in these patients.
-
Sarah Mougalian, Yale Cancer Center3yr[~Albert--Dekker--aldekker@ ] I think we don't know that it is a causative association--but as abemaciclib carries an adjuvant indication (and heavy marketing presence on TV!) and ribociclib has demonstrated overall survival (whereas palbociclib has not), it's something to be aware of... -
Albert Dekker4yrhow we know it is from CK4/6 and not from whatever other reason?